June 14 2021 5:57pm

Affordable, decades-old drug PULM-001 proves promising in the fight against COVID-19

An affordable decades-old drug has been reformulated and repurposed to treat COVID-19 patients. Following FDA and Health Canada’s approval, the drug has now begun phase three of a North American clinical trial. As Global’s Victoria Bakos reports, patient recruitment is launching in two weeks in Quebec and Ontario.

Video Home